Cardiovascular disease is the leading cause of morbidity and mortality in the world. Mutations in the FHL2 (Four and a half LIM domains protein 2) gene are associated with cardiomyopathy in patients. Here, we generated two homozygous knockout lines using CRISPR/Cas9-mediated ablation in a human embryonic stem cell (hESC) WA09 line. These knockout lines exhibit a normal karyotype without expressing FHL2 protein, while maintaining pluripotency and differentiation properties. These isogenic mutation lines will be provided as a disease model for cardiomyopathy studies and drug screening.
Pubmed ID: 29291512 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This polyclonal targets Affinity PurImmunofluorescence ied Goat Anti Rabbit IgG(HRP)
View all literature mentionsThis monoclonal targets alpha Tubulin
View all literature mentionsThis monoclonal targets ITGA2B
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis unknown targets IgG (H+L)
View all literature mentionsThis monoclonal targets Cardiac Troponin T
View all literature mentionsThis monoclonal targets AFP (AFP-11)
View all literature mentionsThis monoclonal targets Nestin
View all literature mentionsThis monoclonal targets Oct-3/4
View all literature mentionsThis polyclonal targets Nanog
View all literature mentions